Top 8 Companies in the Global Insulin Pumps Market in 2025

The global insulin pumps market was valued at USD 4.99 billion in 2024. The market is expected to grow at a CAGR of 6.2% during the forecast period of 2025-2034, with the values likely to reach USD 8.58 billion by 2034. The market is driven by the rising prevalence of diabetes and obesity across the globe.

Insulin pumps are compact, wearable devices designed to deliver insulin continuously throughout the day, mimicking the function of a healthy pancreas. These pumps offer a precise, automated insulin delivery method, allowing individuals with diabetes to efficiently manage their blood sugar levels. They eliminate the need for frequent injections and can be programmed to adjust insulin doses based on real-time glucose readings, enhancing overall diabetes management.

The global insulin pumps market is growing rapidly, owing to the increasing prevalence of diabetes and the adoption of advanced insulin delivery solutions. With innovations in technology, such as the integration of glucose monitors (CGMs), insulin pumps provide more personalized and efficient diabetes care. As patients demand more precise methods for managing diabetes, the market is anticipated to expand, with a focus on improving the ease of use and treatment outcomes.

In April 2023, the FDA approved Medtronic's MiniMed™ 780G insulin pump, the first with meal detection technology and 5-minute auto-corrections. This advancement enhances the management of insulin, thereby propelling growth in the market by fostering efficiency in diabetes care along with improved patient outcomes.

Let’s explore the profile of top companies leading the global insulin pumps market in 2025

1.    Insulet Corporation

Insulet Corporation is one of the leading innovators in the global insulin pump market. The company is known for its Omnipod insulin delivery system. The Omnipod is a tubeless, wearable insulin pump that allows users to manage their diabetes without the hassle of tubing, offering a discreet and flexible solution. With a focus on improving patient experience, the company continues to drive innovation in diabetes care, offering both the Omnipod DASH and Omnipod 5 systems, which integrate with continuous glucose monitoring (CGM) to streamline insulin management.

2.    Medtronic Plc.

Medtronic Plc. is a global leader in medical devices, including advanced insulin pump technology. The company's MiniMed insulin pump systems, give patients an all-inclusive way to manage diabetes. Their insulin pumps are designed to be precise, with integration with other diabetes management tools and a focus on simplifying the daily management of diabetes. The company is a significant player in the insulin pump market, offering solutions that help improve patient outcomes and quality of life.

3.    F. Hoffmann-La Roche AG

F. Hoffmann-La Roche is one of the key companies operating in the diabetes care field, providing a range of products for diabetes management from insulin pumps to others. The company focuses on combining diagnostic solutions with insulin delivery systems. Roche's innovations in this area are directed towards simplifying diabetes care and addressing the need for testing, monitoring, and insulin delivery to enhance patient outcomes and make the management of conditions easier for patients with diabetes.

4.    Tandem Diabetes Care, Inc.

Tandem Diabetes Care is one of the leading companies in the insulin pump market. Its t:slim X2 insulin pump is a major product offered by the company. The t:slim X2 combines well with Dexcom's CGM system, giving real-time data on blood glucose which enhances insulin management. With sleek touch screens and designs, their insulin pumps have an intuitive user interface and customizable insulin delivery options. The company is innovative, improving its products continually to improve diabetes care and offer patients a more flexible, efficient way to control their disease.

5.    Ypsomed AG

Ypsomed is a Swiss market leader in diabetes care. The company is known for its product line, mylife Diabetescare, which includes the mylife YpsoPump insulin pump. The pump is compact and easy to use to deliver insulin to individuals with diabetes. With an aim of delivering patient-friendly, personalized solutions, the company has a robust presence in the global market of insulin pumps. Their products combine innovation with simplicity to ensure effective diabetes management and improve patient quality of life.

6.    Wuxi Apex Medical Co. Ltd.

Wuxi Apex Medical is one of the prominent players in the insulin pump market, offering state-of-the-art insulin delivery systems that focus on efficiency and affordability. Their product lines involve insulin pumps and their companion devices, which have been aimed at better diabetes management. The company focuses on innovation and delivers solutions for enhanced patient outcomes by providing reliable systems for insulin delivery customized according to the diverse needs of diabetic patients globally.

7.    A. Menarini Diagnostics S.r.l

A. Menarini Diagnostics is a major company in the global diabetes care market. By collaborating with other market players, they distribute novel insulin patch pumps. They design compact, wearable insulin pumps for convenience. They are discreet and efficient ways of managing insulin delivery in people with diabetes. The company contributes to the expansion of access to cutting-edge diabetes management tools, positioning itself as a key player in the market.

8.    Sooil Development Co., Ltd

Sooil Development develops and manufactures insulin pumps and other related technologies, including Infusion Sets and the Infusion Pump System. These products are designed to administer precise and efficient insulin infusion to patients with diabetes. The company is dedicated to innovation in the diabetes care market and provides reliable and user-friendly insulin pumps, thus enhancing the convenience of treatment for patients and supporting their management of blood glucose levels. Their focus on product development reinforces their position in the global insulin pumps market.